JP2022530773A5 - - Google Patents

Info

Publication number
JP2022530773A5
JP2022530773A5 JP2021563640A JP2021563640A JP2022530773A5 JP 2022530773 A5 JP2022530773 A5 JP 2022530773A5 JP 2021563640 A JP2021563640 A JP 2021563640A JP 2021563640 A JP2021563640 A JP 2021563640A JP 2022530773 A5 JP2022530773 A5 JP 2022530773A5
Authority
JP
Japan
Prior art keywords
item
car
cells
car polypeptide
polypeptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021563640A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022530773A (ja
JP7595583B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/030435 external-priority patent/WO2020223327A1/en
Publication of JP2022530773A publication Critical patent/JP2022530773A/ja
Publication of JP2022530773A5 publication Critical patent/JP2022530773A5/ja
Priority to JP2024205060A priority Critical patent/JP2025028959A/ja
Application granted granted Critical
Publication of JP7595583B2 publication Critical patent/JP7595583B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021563640A 2019-04-30 2020-04-29 抗原特異的cd19標的化car-t細胞 Active JP7595583B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024205060A JP2025028959A (ja) 2019-04-30 2024-11-26 抗原特異的cd19標的化car-t細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962840774P 2019-04-30 2019-04-30
US62/840,774 2019-04-30
PCT/US2020/030435 WO2020223327A1 (en) 2019-04-30 2020-04-29 Antigen specific cd19-targeted car-t cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024205060A Division JP2025028959A (ja) 2019-04-30 2024-11-26 抗原特異的cd19標的化car-t細胞

Publications (3)

Publication Number Publication Date
JP2022530773A JP2022530773A (ja) 2022-07-01
JP2022530773A5 true JP2022530773A5 (cg-RX-API-DMAC7.html) 2023-05-09
JP7595583B2 JP7595583B2 (ja) 2024-12-06

Family

ID=73029201

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021563640A Active JP7595583B2 (ja) 2019-04-30 2020-04-29 抗原特異的cd19標的化car-t細胞
JP2024205060A Pending JP2025028959A (ja) 2019-04-30 2024-11-26 抗原特異的cd19標的化car-t細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024205060A Pending JP2025028959A (ja) 2019-04-30 2024-11-26 抗原特異的cd19標的化car-t細胞

Country Status (11)

Country Link
US (1) US12617849B2 (cg-RX-API-DMAC7.html)
EP (1) EP3962955A4 (cg-RX-API-DMAC7.html)
JP (2) JP7595583B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220005541A (cg-RX-API-DMAC7.html)
CN (1) CN114026128A (cg-RX-API-DMAC7.html)
AU (1) AU2020265652A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021021608A2 (cg-RX-API-DMAC7.html)
CA (1) CA3138276A1 (cg-RX-API-DMAC7.html)
IL (1) IL287440A (cg-RX-API-DMAC7.html)
MX (1) MX2021013368A (cg-RX-API-DMAC7.html)
WO (1) WO2020223327A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113226340A (zh) 2018-11-26 2021-08-06 恩卡尔塔公司 同时扩增多种免疫细胞类型的方法、相关组合物及其在癌症免疫疗法中的用途
CN109735558B (zh) * 2018-12-12 2022-04-15 中南大学 一种重组car19-il24基因、慢病毒载体、car19-il24-t细胞及应用
US12419913B2 (en) 2019-02-08 2025-09-23 Dna Twopointo, Inc. Modification of CAR-T cells
KR20210137085A (ko) 2019-03-05 2021-11-17 엔카르타, 인크. Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
BR112021021608A2 (pt) 2019-04-30 2021-12-21 Atara Biotherapeutics Inc Células car-t direcionadas a cd19 específicas para antígeno
CA3209218A1 (en) * 2021-01-27 2022-08-04 H. Lee Moffitt Cancer Center And Research Institute Inc. Bi-specific car t cells for b cell malignancies
US20230303655A1 (en) * 2021-10-18 2023-09-28 Kite Pharma, Inc. Signaling domains for chimeric antigen receptors
WO2023122337A1 (en) * 2021-12-23 2023-06-29 Sana Biotechnology, Inc. Chimeric antigen receptor (car) t cells for treating autoimmune disease and associated methods
CN115725001A (zh) * 2022-12-08 2023-03-03 湖南光琇高新生命科技有限公司 靶向cd19的嵌合抗原受体、核酸、重组载体及car-t细胞
WO2024173769A2 (en) * 2023-02-17 2024-08-22 IN8bio, Inc. Non-signaling chimeric antigen receptor gamma delta t-cells
CN116218786B (zh) * 2023-03-09 2024-01-23 山东大学齐鲁医院 一种多重基因编辑的通用型巨噬细胞及在制备抗肿瘤药物中的应用
CN122138982A (zh) * 2023-10-26 2026-06-02 上海先博生物科技有限公司 靶向cd19的嵌合抗原受体的治疗用途
CN119285758B (zh) * 2024-10-31 2025-07-01 上海百英生物科技股份有限公司 一种基于b细胞永生化的单个b细胞抗体开发方法及其应用
CN121673421A (zh) * 2025-10-24 2026-03-17 卡瑞济(北京)生命科技有限公司 一种靶向EGFRvIII的嵌合抗原受体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3858379A1 (en) 2013-11-21 2021-08-04 Autolus Limited Cell
PL3280729T3 (pl) 2015-04-08 2022-08-22 Novartis Ag Terapie cd20, terapie cd22 i terapie skojarzone komórką eksprymującą chimeryczny receptor antygenowy (car) cd19
MX2018001568A (es) * 2015-08-07 2019-04-25 Seattle Children´S Hospital Dba Seattle Children´S Res Institute Celulas t biespecificas de receptor quimerico de antigeno (car) para focalizacion a tumores solidos.
CN106467906B (zh) 2015-08-20 2019-09-27 北京马力喏生物科技有限公司 构建体、转基因淋巴细胞及其制备方法和用途
JP7467117B2 (ja) 2016-10-07 2024-04-15 ノバルティス アーゲー 癌の治療のためのキメラ抗原受容体
CA3049652A1 (en) * 2017-01-10 2018-07-19 Intrexon Corporation Modulating expression of polypeptides via new gene switch expression systems
WO2019060174A1 (en) 2017-09-22 2019-03-28 H. Lee Moffitt Cancer Center And Research Institute, Inc. CHIMERIC ANTIGENIC RECEPTORS WITH ENHANCED NFKB SIGNALING
CN111212663A (zh) 2017-07-07 2020-05-29 H·李·莫菲特癌症中心研究所公司 具有突变的cd28共刺激性结构域的嵌合抗原受体
CN108383914A (zh) 2018-02-23 2018-08-10 北京美康基免生物科技有限公司 一种基于cd19的嵌合抗原受体及其应用
AU2019243315A1 (en) 2018-03-29 2020-09-24 Fate Therapeutics, Inc. Engineered immune effector cells and use thereof
BR112021021608A2 (pt) 2019-04-30 2021-12-21 Atara Biotherapeutics Inc Células car-t direcionadas a cd19 específicas para antígeno

Similar Documents

Publication Publication Date Title
KR102879284B1 (ko) 항-메소텔린 키메라 항원 수용체(car) 작제물 및 이의 용도
JP2020513839A5 (cg-RX-API-DMAC7.html)
IL277398B2 (en) Pd-l1 binding affimers, and uses related thereto
RU2017105160A (ru) Лечение рака с помощью химерного антигенного рецептора к cd33
JP2022109975A5 (cg-RX-API-DMAC7.html)
JP2018527014A5 (cg-RX-API-DMAC7.html)
RU2017108903A (ru) Химерный антигенный рецептор (car) против cd123 для использования в лечении злокачественных опухолей
US20220389075A1 (en) Engineered t cell receptors and uses thereof
JP2017522879A5 (cg-RX-API-DMAC7.html)
JP2019531328A (ja) セレブロン系のヘテロ二量体化可能なキメラ抗原受容体
JP2021530233A5 (cg-RX-API-DMAC7.html)
WO2017079705A1 (en) Chimeric receptors containing traf-inducing domains and related compositions and methods
CA3080109A1 (en) Cd38-directed chimeric antigen receptor constructs
JP2024517027A5 (cg-RX-API-DMAC7.html)
US20230257441A1 (en) Compositions and methods for treating cancers
JP2024534847A5 (cg-RX-API-DMAC7.html)
AU2021328478A1 (en) Compositions and methods for treating egfr positive cancers
JP2022538425A5 (cg-RX-API-DMAC7.html)
JP2025511409A5 (cg-RX-API-DMAC7.html)
JP2023518930A5 (cg-RX-API-DMAC7.html)
WO2021252635A1 (en) Compositions and methods for treating cancers
JP2025513427A5 (cg-RX-API-DMAC7.html)
US20240261330A1 (en) CD19-Directed Chimeric Antigen Receptor Constructs
JP2023518931A5 (cg-RX-API-DMAC7.html)
EP4712986A1 (en) Immune cells with paired receptors and uses thereof